Skip to content

CLINICAL EVALUATION OF SIDDHA MEDICINE ARPUTHA MATHIRAI FOR THE MANAGEMENT OF SOOTHAGA VAAYU ( PCOS)

PHASE II NON RANDOMIZED OPEN CLINICAL EVALUATION OF SIDDHA MEDICINE ARPUTHA MATHIRAI FOR THE MANAGEMENT OF SOOTHAGA VAAYU ( PCOS)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047285
Enrollment
40
Registered
2022-11-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Arputha Mathirai: Arputha Mathirai is a herbo mineral Siddha formulation. Literature evidences support the use of ingredients of the formulation in the management of PCOS. Intervention

Sponsors

Dr Dowlathunnissa Begum G
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married / Unmarried women aged between 15-40 years, Polycystic ovary in ultra sound (unilateral/bilateral). Amenorrhoea, Married women with primary infertility, Irregular menstruation, Ovulation related infertility, Oligomenorrhoea, All above criteria with or without hypothyroidism.

Exclusion criteria

Exclusion criteria: Hyperthyroidism, Congenital uterine defects, Pituitary/Adrenal disorders, Hemorrhagic cyst / Chocolate Cyst, Any serious systemic illness, Tuberculosis of the ovary and uterus

Design outcomes

Primary

MeasureTime frame
Disappearance / Reduction in the size or number of cysts in ultra sound, ovulation or regulation of menstrual and hormonal profile. Any one or more among the above in a period of 2 or 3 weeks or more during the course of the study will be considered as primary outcome.Timepoint: The outcomes will be assessed after a period of 48 days.

Secondary

MeasureTime frame
1.Safety and efficacy of the drug will be assessed during the course of the study. Timepoint: Safety and efficacy will be assessed in a time period of 48 days.

Countries

India

Contacts

Public ContactDr Dowlathunnissa Begum G

Government Siddha Medical College,Arumbakkam, Chennai.

chittu758@gmail.com9444177230

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026